Fiscal 2026 full-year guidance raised to $3.035 billion-$3.075 billion in sales and $11.80-$12.00 in adjusted EPS.
Future North American semiconductor capacity buildout is identified as an incremental demand opportunity not yet reflected in orders.
CapstanAG integration into a Topeka, Kansas footprint is intended to expand North American precision agriculture sales to mid-tier OEMs.
Medical components business is expected to return to ongoing mid-single-digit-plus growth as demand normalizes.
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Nordson Corporation and 4,900+ companies.